Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.
Quality improvement must measure more than average care quality and change to address the root causes of health inequity, according to a Northwestern Medicine editorial published in The BMJ.
Northwestern Medicine investigators have discovered the epigenetic mechanisms involved in the regulation of two oncogenes in glioma cells, which may improve personalized approaches to treat these cancers.
Northwestern Medicine investigators have discovered that a subset of proteins in mitochondria of brain and heart cells are long-lived, supporting the long-term stability of mitochondrial complex architecture.
As part of their Introduction to the Profession Module, first-year medical students had the opportunity to shadow Northwestern Memorial Hospital healthcare professionals and gain focused hospital experience.
A study led by Northwestern Medicine investigators has identified the molecular mechanisms within protein complexes that promote cell-to-cell adhesion and communication.
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
Thirty-five years since it was started, the Coronary Artery Risk Development in Young Adults study, or CARDIA, has become a premier source for the determinants, mechanism and outcomes of cardiovascular disease and manifestations of aging.